# MGB Biopharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mgb-biopharma

- Industry: Biotechnology
- Headquarters: Bellshill, UK
- Website: www.mgb-biopharma.com
- Total disclosed funding: $7.7M
- Latest round: Series B (Jul 18, 2013)
- Investors on record: 5

## About

MGB Biopharma Limited is a UK-based biotechnology firm that focuses on developing and commercializing innovative antimicrobial products to combat antibiotic resistance.Founded in 2010 in Bellshill, UK, MGB Biopharma Limited specializes in antimicrobial development. The company has engaged in 9 deals, with the latest funding round occurring on August 3, 2021, where they raised GBP 175,000 from investors including Barwell and Scottish Enterprise. CEO Miroslav Ravic leads the company, which currently has a valuation of GBP 9.22 million.MGB Biopharma specializes in developing innovative antimicrobial products aimed at addressing antibiotic resistance. Their proprietary portfolio targets various resistant bacterial infections to improve clinical outcomes for patients facing difficult-to-treat conditions. The company supplies its solutions to healthcare providers, hospitals, and pharmaceutical companies across Europe and North America, focusing on enhancing patient care and healthcare system efficiency.In the most recent year, 2021, MGB Biopharma generated no revenue, with an EBITDA of -GBP 722,841. The company engages in B2B transactions, supplying antimicrobial products primarily through bulk purchasing agreements and long-term contracts with healthcare institutions.MGB Biopharma plans to utilize funding raised in August 2021, amounting to GBP 175,000, to support the development of new antimicrobial products and expand into additional markets. Specific regions targeted for growth have yet to be disclosed, but the company aims to enhance its presence within the existing European and North American markets while exploring further international opportunities.

## Funding rounds

- Series B, Jul 18, 2013, $4.9M — Archangel Ventures, Barwell, Scottish Enterprise, TRICAPITAL
- Series A, Mar 31, 2010, $2.8M — Archangels Investors Limited, Barwell, Scottish Enterprise, TRICAPITAL

## Investors

- Archangels Investors Limited — Series A
- Barwell (https://capitalatlas.ai/funds/barwell) — Series A, Series B
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A, Series B
- TRICAPITAL (https://capitalatlas.ai/funds/tricapital) — Series A, Series B
- Archangel Ventures (https://capitalatlas.ai/funds/archangel-ventures) — Series B